Humans—even before we are born—are exposed to a wide range of chemicals. Through the air air we breathe, the soil we walk upon and even the common household products we use, thousands of chemical toxicants make their way into human beings. Epidemiologists determine, through rigorous study, which of these chemical exposures are harmful to our health.
This Thursday Professor Enrique Schisterman delivered a presentation to Brown students, staff and faculty on an innovative approach to studying mixtures of chemicals and determining which exposures may contribute to adverse health outcomes.
Schisterman, Perelman Professor and chair of the Department of Biostatistics, Epidemiology and Informatics in the Perelman School of Medicine at the University of Pennsylvania, is renowned for his contributions to reproductive epidemiology and epidemiological methods.
His clinical research includes several landmark randomized trials, including the Effects of Aspirin on Gestation and Reproduction Trial, which demonstrated that low-dose aspirin increases live birth rates in women with prior pregnancy loss and chronic inflammation.
Schisterman currently serves as principal investigator on both the APPLE Trial and a PCORI-funded grant developing transportability methods for randomized trials, continuing his work at the intersection of clinical intervention research and methodological development.
His talk at Brown, “The Limits of Detection as a Regression Continuity: What a laboratory threshold can and cannot tell us about low-level chemical mixtures,” was part of the Department of Epidemiology’s 2026 Seminar Series. In it, he explored a new approach to understanding the health effects of environmental exposures, particularly the challenge of studying mixtures of chemicals and determining which exposures may contribute to adverse health outcomes.